Discrepancies in the reported prognostic significance of ERG rearrangements can be due to cohort design (multifocality and zonal origin of the tumor), fusion detection technique, and are also liable to the primary end point of the study (i.e., biochemical recurrence, overall survival). The gene discussed is ERG; the disease is neoplasm.